These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8920174)

  • 21. Declarative memory.
    Riedel WJ; Blokland A
    Handb Exp Pharmacol; 2015; 228():215-36. PubMed ID: 25977084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The NMDA receptor as a target for cognitive enhancement.
    Collingridge GL; Volianskis A; Bannister N; France G; Hanna L; Mercier M; Tidball P; Fang G; Irvine MW; Costa BM; Monaghan DT; Bortolotto ZA; Molnár E; Lodge D; Jane DE
    Neuropharmacology; 2013 Jan; 64():13-26. PubMed ID: 22796429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 25. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation.
    Dumas JA; Newhouse PA
    Pharmacol Biochem Behav; 2011 Aug; 99(2):254-61. PubMed ID: 21382398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing cognition through pharmacological and environmental interventions: Examples from preclinical models of neurodevelopmental disorders.
    Morè L; Lauterborn JC; Papaleo F; Brambilla R
    Neurosci Biobehav Rev; 2020 Mar; 110():28-45. PubMed ID: 30981451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014.
    Froestl W; Muhs A; Pfeifer A
    J Alzheimers Dis; 2014; 42(1):1-68. PubMed ID: 24903780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.
    Araujo JA; Studzinski CM; Milgram NW
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):411-22. PubMed ID: 15795050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of drugs against dementia on cognition in aging and mild cognitive impairment.
    Ihl R
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S38-43. PubMed ID: 13130387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for preservation of memory function in patients with brain metastases.
    Dye NB; Gondi V; Mehta MP
    Chin Clin Oncol; 2015 Jun; 4(2):24. PubMed ID: 26112810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins and cognitive function in the elderly: the Cardiovascular Health Study.
    Bernick C; Katz R; Smith NL; Rapp S; Bhadelia R; Carlson M; Kuller L;
    Neurology; 2005 Nov; 65(9):1388-94. PubMed ID: 16275825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognition as a target in major depression: new developments.
    Solé B; Jiménez E; Martinez-Aran A; Vieta E
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):231-47. PubMed ID: 25640673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of cognitive enhancers in animal models of fear extinction.
    Kaplan GB; Moore KA
    Pharmacol Biochem Behav; 2011 Aug; 99(2):217-28. PubMed ID: 21256147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
    Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
    Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.
    Froestl W; Muhs A; Pfeifer A
    J Alzheimers Dis; 2012; 32(4):793-887. PubMed ID: 22886028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
    Bruce J; Hancock L; Roberg B; Brown A; Henkelman E; Lynch S
    Cogn Behav Neurol; 2012 Sep; 25(3):107-14. PubMed ID: 22960434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for delivering and evaluating the efficacy of cognitive enhancement.
    Harvey PD; Keefe RS
    Handb Exp Pharmacol; 2015; 228():5-25. PubMed ID: 25977078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.
    Cannon CE; Puri V; Vivian JA; Egbertson MS; Eddins D; Uslaner JM
    Neuropharmacology; 2013 Jan; 64():191-6. PubMed ID: 22659472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive enhancement: promises and perils.
    Hyman SE
    Neuron; 2011 Feb; 69(4):595-8. PubMed ID: 21338872
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.